Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $105.58 million. The enterprise value is $71.59 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NKTR has 12.41 million shares outstanding. The number of shares has increased by 9.53% in one year.
Current Share Class | 12.41M |
Shares Outstanding | 12.41M |
Shares Change (YoY) | +9.53% |
Shares Change (QoQ) | -1.25% |
Owned by Insiders (%) | 1.39% |
Owned by Institutions (%) | 67.01% |
Float | 12.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.36 |
Forward PS | 2.33 |
PB Ratio | 7.69 |
P/TBV Ratio | 7.69 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.82 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 13.59.
Current Ratio | 3.24 |
Quick Ratio | 3.11 |
Debt / Equity | 13.59 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.07 |
Financial Efficiency
Return on equity (ROE) is -189.46% and return on invested capital (ROIC) is -31.27%.
Return on Equity (ROE) | -189.46% |
Return on Assets (ROA) | -26.80% |
Return on Invested Capital (ROIC) | -31.27% |
Return on Capital Employed (ROCE) | -75.46% |
Revenue Per Employee | $1.43M |
Profits Per Employee | -$2.18M |
Employee Count | 61 |
Asset Turnover | 0.27 |
Inventory Turnover | n/a |
Taxes
Income Tax | -152,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.23% in the last 52 weeks. The beta is 0.56, so NKTR's price volatility has been lower than the market average.
Beta (5Y) | 0.56 |
52-Week Price Change | -50.23% |
50-Day Moving Average | 10.00 |
200-Day Moving Average | 14.16 |
Relative Strength Index (RSI) | 42.04 |
Average Volume (20 Days) | 352,632 |
Short Selling Information
The latest short interest is 11.30 million, so 91.12% of the outstanding shares have been sold short.
Short Interest | 11.30M |
Short Previous Month | 10.66M |
Short % of Shares Out | 91.12% |
Short % of Float | 92.41% |
Short Ratio (days to cover) | 5.89 |
Income Statement
In the last 12 months, NKTR had revenue of $87.25 million and -$133.04 million in losses. Loss per share was -$9.52.
Revenue | 87.25M |
Gross Profit | 65.10M |
Operating Income | -139.83M |
Pretax Income | -177.16M |
Net Income | -133.04M |
EBITDA | -136.62M |
EBIT | -139.83M |
Loss Per Share | -$9.52 |
Full Income Statement Balance Sheet
The company has $218.63 million in cash and $186.66 million in debt, giving a net cash position of $33.99 million or $2.74 per share.
Cash & Cash Equivalents | 218.63M |
Total Debt | 186.66M |
Net Cash | 33.99M |
Net Cash Per Share | $2.74 |
Equity (Book Value) | 13.74M |
Book Value Per Share | 1.11 |
Working Capital | 158.98M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$176.87 million and capital expenditures -$1.31 million, giving a free cash flow of -$178.19 million.
Operating Cash Flow | -176.87M |
Capital Expenditures | -1.31M |
Free Cash Flow | -178.19M |
FCF Per Share | -$14.36 |
Full Cash Flow Statement Margins
Gross margin is 74.61%, with operating and profit margins of -160.27% and -152.49%.
Gross Margin | 74.61% |
Operating Margin | -160.27% |
Pretax Margin | -152.66% |
Profit Margin | -152.49% |
EBITDA Margin | -156.59% |
EBIT Margin | -160.27% |
FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.53% |
Shareholder Yield | -9.53% |
Earnings Yield | -126.01% |
FCF Yield | -168.77% |
Analyst Forecast
The average price target for NKTR is $73.75, which is 766.63% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $73.75 |
Price Target Difference | 766.63% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | -1.07% |
EPS Growth Forecast (5Y) | -44.45% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.0666667:1.
Last Split Date | Jun 9, 2025 |
Split Type | Reverse |
Split Ratio | 0.0666667:1 |
Scores
NKTR has an Altman Z-Score of -20.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -20.1 |
Piotroski F-Score | 3 |